Yusuf Yazici
Rheumatology · New York, NYNPI 1669455085
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.5%. Among rheumatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 439 payments — averaging $360.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$36K
- Novartis$21K
- Janssen Scientific Affairs, LLC$17K
- AbbVie$15K
- Bristol Myers Squibb$14K
- Amgen$12K
- plus $43K from 11 others
Across 10 payments — averaging $4599.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$29K
- Amgen$17K
What the payments were for
- Consulting fees$62,43939%
- Speaking & faculty fees$55,16935%
- Travel & lodging$36,06423%
- Food & beverage$4,5383%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 59 | $35,535 |
| Novartis | 81 | $21,337 |
| Janssen Scientific Affairs, LLC | 114 | $16,962 |
| AbbVie | 52 | $14,783 |
| Bristol Myers Squibb | 11 | $14,420 |
| Amgen | 9 | $12,225 |
| Argenx US, Inc. | 6 | $11,563 |
| E.r. Squibb & Sons, L.L.C. | 39 | $9,170 |
| Chugai Pharmaceutical Co., Ltd. | 6 | $7,250 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $4,680 |
| Sanofi | 18 | $2,980 |
| Lilly USA, LLC | 9 | $2,928 |
| Ferring Pharmaceuticals AS | 1 | $1,750 |
| Genentech USA, Inc. | 8 | $1,061 |
| Genentech, Inc. | 18 | $789 |
| Aurinia Pharma U.S., Inc. | 5 | $421 |
| Assertio Therapeutics, Inc. | 2 | $355 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$158,210 in reported general payments places this provider in the 95th percentile of 541 rheumatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $1,099 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $1,094 |
| Hydroxychloroquine Sulfate | 16 | $707 |
| Prednisone | 31 | $479 |
| Alprazolam | 13 | $291 |
| Meloxicam | 17 | $206 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in New York
- Laurie GlimcherNew York$3.9M
- Grace WrightNew York$3M
- Sergio SchwartzmanNew York$2.5M
- Allan GibofskyNew York$1.9M
- Petros EfthimiouNew York$791K
- Olga PetrynaNew York$509K
- Danielle PeterselNew York$461K
- Jose ScherNew York$446K
- Jason FallerNew York$357K
- Lindsay LallyNew York$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.